ClC-5 is an integral plasma membrane protein that belongs to the CLC family of voltage-gated chloride channels [1] . ClC-5 is encoded by the CLCN5 gene, which is located on Xp11. 22 and is predominantly expressed in the kidney [2] . Mutations in CLCN5 are associated with Dent's disease, an X-linked renal tubular disorder characterized by low-molecular-weight proteinuria (LMWP) and renal Fanconi syndrome, associated with hypercalciuria, nephrocalcinosis, and nephrolithiasis [3, 4] . Studies in heterologous expression systems have shown that these mutations abolish or markedly reduce the outwardly rectifying chloride currents generated by ClC-5 [3] .
The segmental expression of ClC-5 in the mature human and rat kidney includes the proximal tubule (PT), the thick ascending limb (TAL) of Henle's loop, and the a-type intercalated cells (IC) of the collecting duct (CD) [5] [6] [7] . The codistribution of ClC-5 with the vacuolar H + -ATPase in endosomes suggests that both proteins could interact to regulate endosomal acidification [5, 7] and apical targeting [8] in PT cells. The interaction between ClC-5 and H + -ATPase may also be important for the urinary acidification mediated by a-type IC [5] [6] [7] . These hypotheses are supported by the major defect in receptor-mediated endocytosis associated with PT dysfunction reported in ClC-5-deficient mice [9, 10] , as well as by the alterations in polarity and expression of H + -ATPase observed in PT cells and IC from patients with Dent's disease [8] .
The clinical manifestations of Dent's disease, including hematuria, proteinuria, mild polyuria, and nephrolithiasis may often occur during childhood, and LMWP is a consistent feature of the disease [4] . In particular, the early onset of some cases [11, 12] , in which tubular proteinuria was discovered in the first month of life, suggests that segmental expression of ClC-5 in PT must be acquired before birth. Developmental studies in rats have shown that assembly of brush border components coincides with the onset of glomerular filtration [13] , but the status of other components of the endocytic pathway in PT cells, such as ClC-5 and H + -ATPase, is not known. Similarly, studies in rat kidney have shown that IC appear during late nephrogenesis and undergo postnatal maturation [14] . However, unlike rats, nephrogenesis in mouse and humans is essentially achieved at birth, and the pattern of appearance and differentiation of IC in these two species remains unclear.
In this study, we have investigated the renal ontogeny, processing, and distribution of ClC-5 during mouse and human nephrogenesis, in parallel with that of the vacuolar H + -ATPase, which provides the driving force for endosomal acidification in PT cells [15] , type II carbonic anhydrase (CAII), which is essential for Na + reabsorption and urinary acidification in PT cells [16] , and the water channel aquaporin-1 (AQP1) as an ontogeny marker for PT cells [17] . These studies provide new insights into the maturation of PT and IC during nephrogenesis and help to understand the role of ClC-5 and the early phenotypic variants of Dent's disease.
METHODS

Human and mouse kidney samples
Human fetal kidneys from therapeutic abortion were procured by the International Institute for Advancement of Medicine (Philadelphia, PA, USA), the Anatomic Gift Foundation (Woodbine, GA,USA), and the Necker Hospital (Paris, France). Eighteen human fetal kidneys, ranging from 12 to 25 weeks of gestation (GW), were used for immunoblotting and immunostaining studies. For comparison and additional studies, we also used 3 newborn or infant human kidneys ranging in age from 4 months to 2 years. These normal kidneys were obtained directly at surgery and perfused with ice-cold neutral buffered salt solutions before processing for fixation and/or protein extraction [7, 17] . The use of these samples conformed to local ethical guidelines and were approved by the University of Louvain Ethical Review Board.
Mouse kidney samples were obtained from CD-1 mice (Iffa Credo, Brussels, Belgium). Pregnant mice were sacrified by cervical dislocation, and embryos were dissected under a binocular to isolate kidneys. An average of 12 embryos from 4 different litters were collected every day from embryonic day 13.5 (E13.5) until day 5 after birth (newborn). Comparative studies were performed with 4 adult male kidneys. Kidney samples from wild-type versus ClC-5 knockout (KO) mice [10] and adult male Wistar rats were also used.
Antibodies
Affinity-purified polyclonal antibodies (SB499) directed against the N-terminus of human ClC-5 have been characterized previously [10] . Other antibodies included a monoclonal antibody against the 31 kD E subunit (V1 domain) of the vacuolar H + -ATPase (a gift of Dr. S. Gluck, Washington University, St. Louis, MO, USA), a rabbit polyclonal antibody against the 116 kD a4 subunit (V0 domain) of the vacuolar H + -ATPase [18] , a monoclonal antibody against b-actin (Sigma, St. Louis, MO, USA), a rabbit polyclonal antibody against AQP1 (Chemicon, Temecula, CA, USA), and sheep polyclonal antibodies against CAII (Serotec, Oxford, UK) and Tamm-Horsfall protein (Biodesign International, Kennebunk, ME, USA).
Immunoblot analyses and deglycosylation studies
Membrane extracts were prepared as previously described [7, 10] . Briefly, kidney samples were homogenized in ice-cold buffer (300 mmol/L sucrose and 25 mmol/L N-2-hydroxyethylpiperazine-N -2-ethanesulfonic acid made to pH 7.0 with 1 mol/L tris (hydroxymethyl)aminomethane [Tris]) containing Complete TM protease inhibitors (Roche, Vilvoorde, Belgium). The homogenate was centrifuged at 1000g for 15 minutes at 4
• C, and the resulting supernatant was centrifuged at 100,000g for 120 minutes at 4
• C. The pellet ("membrane" fraction) was suspended in ice-cold homogenization buffer before determination of protein concentration and storage at -80
• C. Deglycosylation studies were performed on human and mouse kidney extracts and control glycoproteins (Roche). The samples (15 lg total protein) were incubated for 60 to 90 minutes at 37
• C with 12 units of Nglycosidase F, as recommended by the manufacturer.
Immunoblotting was performed as previously described [7, 10] . After blocking, membranes were incubated overnight at 4
• C with primary antibodies, washed, incubated for 1 hour at room temperature with appropriate peroxidase-labeled antibodies (Dako, Glostrup, Denmark), washed again, and visualized with enhanced chemiluminescence. Normalization for b-actin was obtained after stripping the blots and reprobing with the anti-b-actin antibody. Specificity of the immunoblot was determined by incubation with: (1) preimmune rabbit serum; (2) nonimmune rabbit or mouse immunoglobulin (Ig)G (Vector Laboratories, Burlingame, CA, USA) or control ascites fluid (Sigma); and (3) anti-ClC5 antibody preadsorbed with a 5-fold (w/w) excess of immunogenic peptide. Determination of the molecular mass was obtained by comparison with different precision standards (MBI Fermentas, Vilnius, Lithuana; Bio-Rad, Hercules, CA, USA). Densitometry analysis of the specific bands was performed with a Hewlett Packard Scanjet model IVC using the National Institutes of Health (NIH) Image V1.60 software, and optical densities normalized to b−actin density in the corresponding sample. All immunoblots were at least performed in duplicate.
RT-PCR and semiquantitative RT-PCR
Mouse kidney samples were homogenized in Trizol (Invitrogen, Merelbeke, Belgium) in order to extract total RNA. Total RNA samples (2.7 lg) were treated with DNase I (Invitrogen) and reverse-transcribed into cDNA using SuperScript II Rnase H Reverse Transcriptase (Invitrogen). The following primers were designed using Beacon Designer 2.0 (Premier Biosoft International, Palo Alto, CA, USA): ClC-5 (exon 6) sense 5 AAGTGG ACCCTTGTCATCAA 3 and antisense 5 ACAAG ATGTTCCCACAGCAG 3 , AQP1 (exons 1-2) sense 5 GCTGTCATGTATATCATCGCCCAG 3 and antisense 5 AGGTCATTTCGGCCAAGTGAGT 3 , GAPDH (exon 1) sense 5 TGCACCACCAACTGCTTAGC 3 and antisense 5 GGATGCAGGGATGATGTTCT 3 . The predicted lengths of the resulting PCR fragments were 115 bp (ClC-5), 107 bp (AQP1), and 176 bp (GAPDH). RT-PCR reactions were performed with 200 nmol/L of both sense and antisense primers in a final volume of 25 lL using 1 unit of Platinum Taq DNA polymerase, 2 mmol/L MgCl 2 , 400 lmol/L dNTP. PCR conditions were 94
• C for 5 minutes followed by 35 (ClC-5), 36 (AQP1), and 30 (GAPDH) cycles of 30 seconds at 95
• C, 30 seconds at 61
• C, and 1 minute at 72
• C. The PCR products were size-fractionated on 1.5% agarose gel and then stained with ethidium bromide. Negative controls confirmed that the samples were not crosscontaminated (sterile water instead of RNA) or polluted by genomic DNA (not reverse-transcribed RNA samples). The expression of ClC-5 was also verified using another set of primers (exons 8-9), sense 5 TCC GCACAAACATTGCCTG 3 and antisense 5 AGGC AGCAGCCCCAACCAT 3 (predicted length of the fragment: 519 bp).
Real-time PCR analyses were performed in duplicate with 200 nmol/L of both sense and anti-sense primers in a final volume of 25 lL using 1 U of Platinum Taq DNA Polymerase, 2 mmol/L MgSO4, 400 lmol/L dNTP, and SYBR Green I (Molecular Probe, Leiden, The Netherlands) diluted to 1/10 5 . PCR mixture contained 10 nmol/L fluorescein for initial well to well fluorescence normalization. PCR conditions were settled as incubation at 94
• C for 3 minutes followed by 40 cycles of 30 seconds at 95
• C. The melting temperature of PCR product was checked at the end of each PCR by recording SYBR green fluorescence increase upon slowly renaturating DNA. For each assay, standard curves were prepared by serial 4-fold dilutions of mouse adult kidney cDNA. The mRNA levels of ClC-5 and AQP1 were adjusted to GAPDH mRNA level at each stage, and relative changes in mRNA levels during ontogeny were determined by comparison to the adult mRNA level using the following formula: Ratio = (E target )
Ct(Adult-Sample) /(E GAPDH ) Ct(Adult-Sample) [19] .
Immunostaining
Kidney samples were fixed in 4% paraformaldehyde (Boehringer Ingelheim, Heidelberg, Germany) in 0.1 mol/L phosphate buffer, pH 7.4, prior to embedding in paraffin as described [7, 10, 17] . Six lm sections were incubated for 30 minutes with 0.3% hydrogen peroxide to block endogenous peroxidase. For ClC-5 and H + -ATPase immunostaining, antigen retrieval was performed by incubating sections in 0.01 mol/L citrate buffer, pH 5.8, for 75 minutes, in a water bath heated at 97
• C, before cooling down and rinsing. Following incubation with 10% normal serum for 20 minutes, sections were incubated for 45 minutes with the primary antibodies diluted in phosphate-buffered saline (PBS) containing 2% bovine serum albumin (BSA). After washing, sections were successively incubated with biotinylated secondary anti-immunoglobulin (Ig)G antibodies, avidin-biotin peroxidase, and aminoethylcarbazole (Vectastain Elite, Vector Laboratories). Sections were viewed under a Leica DMR coupled to a Leica DC300 digital camera (Leica, Heerbrugg, Switzerland). The specificity of immunostaining was tested by incubation: (1) in absence of primary antiserum; (2) with preimmune rabbit serum; (3) with non-immune rabbit serum or control rabbit or mouse IgG (Vector Laboratories); and (4) with the anti-ClC-5 antibody preadsorbed with the immunogenic peptide. The intensity of immunostaining was graded by an observator unaware of the embryonic stage and the antibody used, in comparison with the intensity observed in adult samples.
RESULTS
Comparative ontogeny of ClC-5 in the mouse kidney
ClC-5 was detected as a broad band at ∼80 kD in the adult mouse kidney (Fig. 1A) . The band was not detected in kidney extracts from Clcn5 KO mouse (left panel), or when the blot was incubated with anti-ClC-5 antibodies preadsorbed with the immunogenic peptide (right panel). The signal for ClC-5 observed in embryonic samples was different from the adult (right panel); it included two bands at ∼90 kD and ∼75 kD, respectively, separated by a smear of diffuse immunoreactive bands. With the exception of the upper band at ∼90 kD, all the immunoreactive bands were abolished when using preadsorbed antibodies (right panel).
The expression of ClC-5 in the developing kidney was already detected at E13.5 ( Fig. 1B) . At this early stage, the immunoreactive pattern was characterized by the nonspecific upper band at ∼90 kD, and the diffuse specific bands including the ∼75 kD band. The signal intensity for ClC-5 peaked early (E14.5), and remained quite stable to E16.5. From E16.5 to the newborn stage, the immunoreactivity pattern for ClC-5 showed a progressive decrease in the higher molecular mass isoforms and apparition of a more focused signal around 75 to 80 kD. Adult samples were characterized by concentrated immunoreactive bands around 80 kD, as described above. The expression of AQP1 in the kidney is characterized by two isoforms-the core AQP1 (28 kD) and the glycosylated AQP1 (GlyAQP1, 35 to 50 kD). The core AQP1 was detected at E15.5 and it gradually increased during late ontogeny. The GlyAQP1 was detected only at E18.5 and in the newborn kidney, probably reflecting the increased amount of AQP1 [17] . The 31 kD band corresponding to the E1 subunit of the H + -ATPase was detected at low level from E13.5 and showed a gradual increase from E16.5 to birth. A progressive induction of the 116 kD a4 subunit of the H + -ATPase from E16.5, in parallel with the E subunit, was observed in developing mouse kidney (data not shown). The CAII band at 30 kD was detected at E14.5, remained stable during all ontogeny, and showed a dramatic increase postnatally (Fig. 1B) . Densitometry analysis (Fig. 1C) confirmed the different expression patterns of ClC-5, which peaked at E14.5 (170% of adult level), remained high (140% to 150% of adult level) during ontogeny, and decreased after birth, AQP1 and H + -ATPase, which showed a gradual increase from E16.5, and CAII, with low expression levels (15% -30% of adult level) during all ontogeny and a significant postnatal increase.
Quantification of ClC-5 mRNA expression in the developing mouse kidney
Semiquantitative ( Fig. 2A ) and real-time PCR analyses (Fig. 2B) confirmed the early induction of ClC-5 at were stripped and reincubated with a monoclonal antibody against b-actin (1:10,000). Right: Adult and fetal (E18.5) mouse kidney extracts (20 lg/lane) were run on 7.5% PAGE and transferred to nitrocellulose. Identical strips were probed with control (SB499; 1:1000) or preadsorbed (PreAd; 1:1000) SB499 anti-ClC-5 antibodies. With the exception of the nonspecific upper band at ∼90 kD detected in fetal samples, the distinct signal corresponding to ClC-5 in mature and developing kidney is abolished when incubation is performed with preadsorbed antibodies. Reprobing for b-actin was performed as above. (B) Representative immunoblots for ClC-5 in extracts from adult rat (positive control, C) and mouse at different stages-from E13.5 to E18.5, neonates (NB) and adults. Twenty lg of protein were loaded in each lane, and blots were probed with antibodies against ClC-5 (1:1000), AQP1 (1:20,000), H + -ATPase (1:100), CAII (1:1000), and after stripping, b-actin (1:10,000). ClC-5 is detected at E13.5, upregulated at E14.5, and then sustained during ontogeny. The immunoreactive pattern is also clearly different in the early (higher molecular mass bands) and late stages (focused immunoreactive bands around 75-80 kD) of maturation. The expression of AQP1 and H + -ATPase gradually increases from E16.5 and during late ontogeny, whereas CAII expression is characterized by post-natal upregulation. , and GAPDH were similar to those used above. The ClC-5 and AQP1 mRNA levels were adjusted to GAPDH for each stage. The relative changes in expression during ontogeny were determined by comparison to the adult mRNA level taken as 100%. ClC-5 mRNA is significantly expressed at E13.5 (70% of the adult value), with a subsequent decrease until E17.5 (30%) and a major 2-fold upregulation at birth. This expression pattern contrasts with the low level of AQP1 at E13.5 (4% of the adult value) and its gradual increase from E15.5 (6%) to nearly reach the adult level at birth (73%).
E13.5, with a slight decrease of expression during late ontogeny, and a dramatic 2-fold increase in newborns. This expression pattern contrasted with that of the water channel AQP1, which showed a later induction at the end of nephrogenesis to nearly reach the adult level at birth.
Processing of ClC-5 during mouse nephrogenesis: Deglycosylation studies
Sequence analysis predicted that ClC-5 is a glycoprotein with N-glycans linked to Asn at position 408 [3] . Deglycosylation studies with N-glycosidase F were per- formed in control glycoproteins and developing and adult mouse kidney samples (Fig. 3) . Digestion of transferrin (65 to 60 kD), a1-acid glycoprotein (45 to 22 kD), and ribonuclease B (17 to 15 kD) demonstrated the efficiency of deglycosylation (data not shown). Immunoblot analysis showed that untreated embryonic samples (Fig. 3A) are characterized by diffuse immunoreactive ClC-5 bands (asterisk) located below the nonspecific 90 kD band and a specific, core band at ∼75 kD (arrow). The latter is above a nonspecific immunoreactive band at 60 kD (arrowhead), which results from incubation in reaction buffer. Untreated adult samples (Fig. 3B) showed the mature ClC-5 band at ∼80 kD (asterisk) in addition to the nonspecific band at 60 kD (arrowhead), but not the 75 kD core band (arrow). Treatment with N-glycosidase F yielded a shift of the specific ClC-5-positive bands to a lower apparent molecular weight, indicating the existence of Asn-linked glycan chains in both embryonic and adult samples. To note, the molecular weight of the deglycosylated form of ClC-5 was slightly higher in developing than in mature kidney samples.
Ontogeny and glycosylation of ClC-5 in the human kidney
The broad immunoreactive band corresponding to ClC-5 was detected by immunoblotting in the developing human kidney at 12GW (Fig. 4A) . The intensity of ClC-5 expression was sustained during all nephrogenesis, similar to that observed in the infant kidney. Treatment with N-glycosidase F induced a significant shift of kD −100 Representative immunoblot for ClC-5 in membrane extracts from rat kidney (positive control, RKC), human fetal kidney (HFK) at 12, 13, 18, and 25 GW, newborn (HNK) and infant (HIK) human kidney. Thirty lg of protein were loaded in each lane, and the blot was probed with the anti-ClC-5 antibodies alone (SB499) or preadsorbed (PreAd) (both diluted 1:1000). The broad band corresponding to ClC-5 is detected at 12 GW, and its expression is sustained during nephrogenesis. The ClC-5 signal is abolished when incubation is performed with preadsorbed antibodies. Discrete bands below 60 kD are also detected with nonimmune IgG. (B) Deglycosylation with N-glycosidase F in human kidney samples (25 GW, HFK25; infant, HIK). The samples were incubated with the reaction buffer containing (+) or not (−) N-glycosidase F, separated (7.5 lg protein/lane) on 7.5% PAGE and probed with anti-ClC-5 antibodies (SB 499 lanes). The shift of ClC-5 bands to a lower molecular weight confirms the existence of Asn-linked glycan chains. As in mouse, the molecular mass of the PGNase F-sensitive ClC-5 proteins is higher in fetal than in postnatal samples. The pattern observed in HIK samples (more diffuse immunoreactive bands including lower mass isoforms) suggests that they may include residual embryonic isoforms. The signal is abolished when a similar blot is incubated with preadsorbed anti-ClC-5 antibodies (PreAd).
ClC-5-positive bands to a lower molecular weight (Fig. 4B) , indicating the existence of Asn-linked glycan chains in developing and mature human kidney samples. As described in mouse, the molecular weight of the deglycosylated form of ClC-5 was higher in fetal than in postnatal samples.
Segmental distribution of ClC-5 during mouse nephrogenesis
ClC-5 was detected in the developing mouse kidney at E13.5 (Fig. 5A) . The signal was located in branching ureteric buds within the inner part of the primitive cortex, whereas the undifferentiated metanephric cap tissue, the condensates, and the inner mesenchyme, were negative. Staining intensity for ClC-5 markedly increased at E14.5, by which dispersed primitive glomeruli were identified (Fig. 5B) . The staining was stronger in the ureteric buds and also appeared in developing PT. Glomeruli, as well as comma-and S-shaped bodies, were all negative. From E15.5 (Fig. 5C ) to E18.5 (Fig. 5D) , ClC-5 staining persisted in ureteric buds, became more apparent in developing PT, and gradually appeared in the IC.
At higher magnification (Fig. 6) , staining for ClC-5 within the primitive cortex of E14.5 kidneys was identified in the apical area of the tips of ureteric buds (Fig. 6A) . A similar staining was observed within branching ureteric buds in the outer part of the primitive medulla (Fig. 6B) , whereas an apical staining restricted to a subpopulation of ureteric buds cells was observed in the inner medulla (Fig. 6C) . At E15.5, ClC-5 was identified in PT originating from recently formed glomeruli, and scattered CD cells (Fig. 6D and inset) . The latter were also stained for apical H + -ATPase, indicating that they correspond to atype IC (see below). At E16.5, ClC-5 showed an homogeneous, subapical staining in cells lining developing PT, and a strong apical staining in IC (Fig. 6E) . To note, codistribution of ClC-5 ( Fig. 6F) and Tamm-Horsfall protein (Fig. 6G) was observed in some juxtaglomerular tubules at E16.5 and later. Distribution of ClC-5 in E18.5 kidneys included the apical area of PT cells and IC of the cortical CD (Fig. 6H) , exactly like in newborn mouse (Fig. 6I) . Codistribution of ClC-5 ( Fig. 6J) and CAII (Fig. 6K ) was observed in postnatal IC. The specificity of ClC-5 staining was demonstrated with preadsorbed SB499 antibodies (data not shown). In comparison with ClC-5, CAII was first identified in IC at E15.5 and PT cells at E16.5, whereas AQP1 was detected in PT cells from E16.5 (data not shown). The distribution of ClC-5 and tubular markers during mouse nephrogenesis is summarized in Table 1 .
Segmental distribution of H + -ATPase during mouse nephrogenesis
Staining for H + -ATPase was detected in the developing mouse kidney at E15.5 (Fig. 7A) . The signal was located in the subapical area of developing PT in the inner cortex (Fig. 7E) , whereas ureteric buds, glomeruli and undifferentiated structures were negative. Apical staining for H + -ATPase was also identified in scattered IC ( Fig. 7F) . A significant increase in H + -ATPase expression was detected at E16.5 (Fig. 7B) , with staining of developing PT and IC in the cortex and inner medulla ( Fig. 7G  and H) . The IC in the medulla were characterized by apical protrusion into the lumen (Fig. 7H) , unlike those observed in the cortex (Fig. 7G) . The distribution of H + -ATPase at E18.5 (Fig. 7C ) was similar to that observed in the newborn mouse kidney (Fig. 7D and I ) and included PT cells (linear, subapical staining) and IC (punctuated, apical staining). H + -ATPase (Fig. 7J and L) and ClC-5 ( Fig. K and M) colocalized in the developing PT and IC as early as E15.5 (see Table 1 for summary). 
Segmental distribution of ClC-5 and H + -ATPase in the developing human kidney
Diffuse staining for ClC-5 was identified in 13GW kidneys, located in developing PT from juxtamedullary nephrons ( Fig. 8A and C) . No specific staining was detected in condensates, comma and S-shaped bodies, and glomeruli. At 19 GW, a slightly more intense staining for ClC-5 was detected in maturing PT (Fig. 8B and D) , whereas no specific staining was detected with preadsorbed SB499 antibodies (Fig. 8E) . The distribution of ClC-5 in developing PT was confirmed in serial sections stained for AQP1; to note, the staining for AQP1 was more polarized than ClC-5 at that stage ( Fig. 8F and  G) . In juxtamedullary nephrons, ClC-5 was also located in juxtaglomerular tubule profiles that were positive for Tamm-Horsfall protein ( Fig. 8H and I ). In contrast with CAII (15GW) and H + -ATPase (19GW), ClC-5 could not be clearly identified in IC until the 24 GW (data not shown). Identification of ClC-5 staining in IC was ascertained postnatally by colocalization with CAII ( Fig. 8J and K).
A faint signal for H + -ATPase (Fig. 9 ) was detected at 13 GW in the apical area of developing PT in the outer cortex, whereas glomeruli and ureteric buds were negative (Fig. 9A) . From 15 GW to 24 GW (Fig. 9B) , a progressive increase in H + -ATPase expression was detected in the subapical area of PT cells. Isolated cells positive for H + -ATPase (Fig. 9B) were also identified in the CD as early as 19 GW (inset of Fig. 9B) . The reactivity for H + -ATPase after birth included a strong signal in the apical area of PT cells and IC of the CD (Fig. 9C) .
DISCUSSION
Our studies show that ClC-5 undergoes a rapid induction at an early stage of mouse nephrogenesis, followed by a progressive maturation during late nephrogenesis. This ontogeny pattern is distinct from the progressive increase of H + -ATPase and AQP1 expression, and the postnatal induction of CAII. Studies with PGNase F confirm the early N-linked glycosylation of ClC-5, and the progressive maturation of the core protein during nephrogenesis. The distribution of ClC-5 in PT and a-type IC, and its colocalization with H + -ATPase in these locations, are already achieved at E15.5 (see Table 1 for summary). In human nephrogenesis, ClC-5 is detected early during the second trimester, with a distribution that includes developing PT cells and later, IC.
Nephrogenesis in mouse and humans is characterized by a repetitive and reciprocal induction between the ureteric bud and the metanephric mesenchyme, resulting in the formation of a mature kidney before birth. In other species, such as rat or rabbit, nephrogenesis continues after birth ( [20] for review). Glomerular filtration starts at E14 in mouse [21] , and between the 9th and 12th GW in the human kidney [22] . The molecular events that take place in renal tubular cells following the onset of glomerular filtration remain partially unknown. The reabsorption of LMW proteins that are freely filtered is confined to PT cells, which are characterized by an intense endocytic activity followed by transport and degradation into the acidic vacuolar-lysosomal system [23] . Indirect evidence in rats [24] and humans [25] suggests that the PT endocytic activity is effective during nephrogenesis or immediately after birth. Furthermore, an increase of transporting membrane area and CA activity, as well as the upregulation of AQP1, has been documented in PT cells during nephrogenesis [17, 22, 26] . In contrast, the ontogeny and distribution of intracellular transporters such as ClC-5 and H + -ATPase during nephrogenesis have not been characterized to date. The issue is particularly relevant for PT maturation, since several lines of evidence suggest that ClC-5 interacts with the vacuolar H + -ATPase [8] and plays an essential role in the megalin receptor-mediated endocytic pathway [5, 7, 9, 10] . Immunoblotting and RT-PCR analyses show that ClC-5 undergoes a rapid induction in the developing mouse kidney, followed by progressive maturation during late ontogeny and a marked induction just after birth (Figs. 1  and 2) . Thus, the developmental pattern of ClC-5 expression in mouse clearly differs from that of another glycoprotein such as AQP1, or the co-expressed H + -ATPase. Studies with PGNase F not only confirmed the early N-glycosylation of ClC-5 [30] but also demonstrated biochemical differences between embryonic and adult ClC-5 proteins. These differences include the higher molecular mass of the PGNase F-sensitive proteins in embryonic versus adult samples, as well as the specific expression in mouse embryonic samples of a ClC-5 isoform (∼75 kD) that is resistant to PGNase F treatment and that may correspond to the "core" ClC-5 protein (Fig. 3) . By analogy with other members of the CLC family, the complex maturation of ClC-5 may result from alternative splicing [27, 28] , post-translational modifications [29] , or covalent binding to proteins that are expressed during nephrogenesis [20] . It is tempting to hypothesize that the transient expression of immature ClC-5 isoforms during ontogeny may correspond to the signal observed in ureteric buds, where there is no colocalization with H + -ATPase, whereas a progressive increase in mature ClC-5 isoforms may actually parallel the induction of H + -ATPase during late nephrogenesis. These results, and the postnatal regulation of CAII (Fig. 1C) , confirm recent evidence showing that differentially regulated genes, including transporters, ion-motive ATPases, and enzymes, can be grouped in clusters that participate in different steps of kidney organogenesis [31] .
As summarized in Table 1 , the segmental expression of ClC-5 and H + -ATPase in PT cells is already detected at E15.5 in mouse (Figs. 5 to 7), and essentially achieved during the second trimester of gestation in humans (Fig. 8) .
These results complete early observations that the apical expression of brush border components and the distribution of megalin to the apical clathrin-coated membrane domains and endosomes coincide with the onset of glomerular filtration in rats [13, 32] . The coexpression of ClC-5 and H + -ATPase in PT cells immediately after initiation of glomerular filtration could thus indicate the progressive maturation of renal tubular function and explain the decrease in the concentration of LMW proteins in the amniotic fluid during gestation [25] . These data also help to understand the pathophysiology of early phenotypic variants of Dent's disease, in which LMWP has been identified during the first weeks of life [11, 12] .
In addition to PT cells, ClC-5 and H + -ATPase are codetected from E15.5 in the apical area of isolated cells within the CD. The apical polarity of both markers allow to identify these cells as a-type IC, which, in the mature kidney, are primarily involved in urinary acidification. Studies in rat have shown that a-type IC simultaneously express H + -ATPase and CAII at the end of the gestation, mature and increase in number during the first weeks of life, and are then partially removed from the CD [14, 33] . Our results provide additional informations on IC maturation in mouse and human nephrogenesis. In mouse nephrogenesis, isolated cells of the medullary ureteric buds, positive for ClC-5, are detected as early as E14.5. IC positive for ClC-5, H + -ATPase, and CAII are observed in the cortical CD at E15.5. In human nephrogenesis, isolated cells positive for CAII are identified within ureteric buds and medullary CD at 15 GW, and rare, isolated cells positive for H + -ATPase are identified at 19 GW. In contrast, ClC-5 could not be identifed in IC before 24 GW. The colocalization of ClC-5 with CAII and/or H + -ATPase in IC was only observed postnatally, confirming data obtained in mature kidney [5, 7] . These results suggest species differences in the maturation of IC [14, 33] and support the hypothesis that, in humans, the differentiation of IC occurs later than that of the principal cells of the CD [17] . Finally, ClC-5 is also located in tubules positive for TammHorsfall protein, a marker of maturation of the TAL of Henle's loop [34] . The location of ClC-5 in maturing TAL confirms observations in mature human and rat kidney [6, 7] . It has been speculated that ClC-5 could play a role in the regulated Ca 2+ reabsorption that occurs in TAL [35] , providing a potential explanation for the hypercalciuria observed both in Dent's disease [4] and ClCn5 KO mice [10] .
CONCLUSION
Our data demonstrate that the segmental distribution of ClC-5 and H + -ATPase is essentially achieved during early nephrogenesis in mouse and the second trimester of gestation in humans. These data provide new insights in the maturation of renal tubules and help to understand the pathophysiology of early phenotypic variants of Dent's disease.
